Spotlight
Video

The benefits of using ramucirumab plus docetaxel in 2nd line NSCLC

obr has 860 videos Subscribe Here

Loading........
Description: Roy S. Herbst, MD, PhD, explains the benefits of using ramucirumab plus docetaxel in 2nd line NSCLC at Annual Meeting 2018.
Shared By : obr
Posted on : 07/18/18
Added : 12 months ago